Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Outlook Therapeutics (41O.F) Q3 2024 Earnings
41O.F
14
Aug
Confirmed
Q2 2024
Q3 2024
-1.42
-1.2
-0.98
-0.75
Details
Expected EPS
-0.937834156
Actual EPS
-0.75364
Surprise EPS
0.18
Surprise Percent
+19.64%
Description
Outlook Therapeutics (41O.F) has reported earnings of -0.75364 per share for Q3 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login